SUMMARY
INTRODUCTION
Neurodegenerative and neurodevelopmental hypothesis are actually two alternative theories to explain schizophrenia (SCH) and bipolar disorder (BD) etiology. Neurodevelopmental hypothesis suggests that a disruption of brain development during early life is responsible for later onset of symptoms, while neurodegenerative hypothesis highlights the "negative" effects of illness . Available data support a contribution of both neurodevelopmental/ neurodegenerative processes in the etiology of these disorders, but the real question is to understand whether specific versus generic damage of brain neurodevelopment is associated later with SCH/BD phenotype and whether neurotoxic effects of illness differ significantly from normal brain aging (Schnack et al. 2016 ). Our hypothesis is that only specific damages, taking places in precise neurodevelopment stages contribute to bipolar/ schizophrenic phenotype and that, after psychopathological onset, there is an acceleration of brain aging ( Figure 1 ). First objective of the present paper is, therefore, to describe the main evidence in support of neurodevelopmental versus neurodegenerative model of SCH/BD. Second objective is to compare etiological models of SCH/BD with physiological neurodevelopment and aging in order to identify the specific risk factors associated with a diagnosis of SCH/BD.
METHODS
A search of articles on MEDLINE, PsycINFO, Isi Web of Knowledge, Medscape was performed in order to obtain a narrative mini-review about the hypothetical etiology of SCH and BD (neurodevelopmental versus neurodegenerative model) compared to physiological brain development and aging. The words "SCH", "BD", "physiology" have been associated with "neurodevelopment", neurodegeneration" and "aging". A manual selection of papers was then performed in order to consider the most recent and relevant articles (controlled studies, review or meta-analyses) concerning with the topic of the present article. 
Head injuries Substance Abuse
Note: in italic the factors associated with increased risk of schizophrenia/bipolar disorder PANDAS: pediatric autoimmune neuropsychiatric disorders; DDT: dichlorodiphenyltrichloroethane 0-6 years: gray matter growth (at the age of six human brain presents 95% of the weight of the adult brain and it has the metabolic peak demand); 6 years-early adulthood: development of white matter and connectivity (Groeschel et al. 2010 ). Each of these phases is particularly sensitive to specific damages that can affect the brain development (Table 1) . However, only some of these "toxic" factors are associated with the development of a future psychiatric condition, while others determine unspecific neurological syndromes. In the following paragraphs factors that have been specifically associated with an increased risk of SCH/BD are described.
Infections of influenza, rubella, herpes simplex viruses and toxoplasma gondii during pregnancy have been all associated with a higher risk of developing SCH and BD (influenza virus and toxoplasma gondii) in the offspring ; Brown 2011; Parboosing et al. 2013). With regard to influenza virus, Parboosing and collaborators found nearly 4-fold increase in the risk of BD (OR= 3.82 95% CI=1.58-9.24) after exposure to maternal influenza at any time during pregnancy (Parboosing et al. 2013) . A study demonstrated that malnutrition during pregnancy determines 2-fold increased risk of SCH in a sample of 52-011 newborns (RR=2.25 95% CI=2.00-2.52) (Xu et al. 2009 ). In addition, children born from 32 to 36 weeks' gestation were found to be more likely to have non-affective psychosis (OR=1.3 95% CI 1.1-1.7) and BD (OR=2.7 95% CI 1.6-4. In childhood low socio-economic status, with related poor nutrition, and parents' neglect, infections (toxoplasma gondii and cytomegalovirus) are all associated with increased risk of future SCH (Brown 2011 
AGING VERSUS NEURODEGENERATION
In normal brain aging, reduced white matter integrity and global cognitive decline (especially in memory and executive domains) have been documented by a number of data (Glahn et al. 2013 ). The speed and intensity of these processes are partly influenced by genetic disposition (Glahn et al., 2013) . In addition, global brain metabolism declines with age, particularly in left inferior frontal junction (Chètelat et al. 2013 ), anterior cingulate/medial prefrontal cortex, dorsomedial thalamus and subgenual cingulate/basal forebrain (Pardo et al. 2007 ). Atrophy of hippocampus and prefrontal cortices are also documented as well as an increase of inflammation and production of free radicals (Buzynska et al. 2012). Interleukin 6 (IL-6) was found to increase with aging and higher levels of this cytokine have been associated with an increased risk of both cardiovascular events and non-cardiovascular death (Akbaraly et al. 2013 ). The inflammatory hypothesis of schizophrenia has recently regained interest also in light of the several data describing the efficacy of some components, such as aspirin or celecoxib, on symptom severity (Sommer et al. 2014 , Andrade 2016 . Similarly TNF-alpha inhibitors have been proposed for the treatment of depression (Schmidt et al. 2014 , Kaster et al. 2016 ). These findings suggest a potential role of the immune system in the pathogenesis of main psychiatric disorders, with important implication for future treatment options of schizophrenia (Girgis et al. 2014) .
Neurotoxic effects of SCH and BD predominantly affect some specific brain areas as an effect of immune dysregulation and with the result of a precise cognitive dysfunction. Similarly to normal aging, the most compromised brain areas in patients with SCH and BD include prefrontal cortex and hippocampus ). In addition, memory and executive functions are highly compromised in SCH and BD patients particularly in individuals with long duration of illness ). Finally, increased IL-6 has been proposed as a common biomarker of immune dysregulation in SCH and BD . In light of these considerations, a very recent publication stated that the net result of biological changes, which are associated with SCH and BD, is an accelerated brain aging (Koutsoluleris et al. 2014)
DISCUSSION
As mentioned above, a limited number of negative effects during neurodevelopment are specifically associated with SCH and BD onset in adulthood. In addition, the damage has to happen in specific stages of neurodevelopment. For example, a number of data indicate that substance abuse (particularly cannabis) during adolescence increases the risk of SCH and BD (De Hert et al. 2011) , while mothers' substance abuse during pregnancy may produce neurological syndromes in the future unborn, but it not certain the association with SCH and BD. Similarly, influenza epidemics in mothers increase the risk of SCH in offspring, but there is no effect of this virus in childhood or adolescence, while cytomegalovirus infections increase the risk of schizophrenia only if they happen during childhood (Brown 2011 ). In contrast, toxoplasma infections are associated with an increased risk of SCH and BD both if the infections occur during pregnancy or childhood (Brown, 2011) . These considerations have two important clinical implications: 1) specific risk factors associated with a significant increased risk of SCH or BD can be reduced 2) high-risk adolescents, who have been exposed during their life to the cited harmful factors, may be more easily identified.
With regard to neurodegeneration, an increasing number of evidence indicates that SCH and BD lead to a premature brain aging so that main target of treatment should be the slowdown of biological changes associated with these conditions (Koutsoluleris et al. 2014; Altamura et al. 2015) .
Finally, further data about the etiology of these disorders will confirm if the model of illness, proposed in this paper, may be definitively recognized as valid.
In conclusion, both neurodevelopment abnormalities and neurodegenerative aspects would appear as valid models to explain the etiology of SCH/BD. The study of physiological neurodevelopment and normal brain aging may help researchers to identify specific risk factors associated with SCH/BD diagnoses. This paper presents some limitations: patients' habits such as smoking, eating and drugs, have to be considered as factors that can impact cytokine leves; furthermore, it has been described that some drugs may increase C-reactive protein levels and may induce fever via cytokines, leading to elevated IL-6 and TNF-α (Štuhec 2013 ). In addition this paper is not a systematic review, being the purpose of the present article to give a concise overview of the etiological models of schizophrenia and bipolar disorder, and of risk factors associated with these mental disorders.
